Richard J. Barohn
Active 1988–2024
- Also published as
- Richard J Barohn
- 148
- Papers
- 29,223
- Citations
- 98
- h-index
- 142
- i10-index
Citations
Citation sources
Countries
Institutions
- Inserm1%
- University College London0.9%
- Johns Hopkins University0.8%
- Sorbonne Université0.7%
- Harvard University0.7%
- University of Oxford0.6%
- Other95.3%
Fields
- Medicine74.7%
- Biochemistry, Genetics and Molecular Biology16.9%
- Neuroscience4.3%
- Immunology and Microbiology2.7%
- Engineering0.2%
- Nursing0.2%
- Other1%
Topics
- Myasthenia Gravis and Thymoma6.4%
- Peripheral Neuropathies and Disorders6.2%
- Inflammatory Myopathies and Dermatomyositis5.4%
- Amyotrophic Lateral Sclerosis Research4.8%
- Muscle Physiology and Disorders4%
- Neurogenetic and Muscular Disorders Research4%
- Other69.2%
Coauthors
- Mazen M. Dimachkie43
- Anthony A. Amato28
- Gil I. Wolfe23
- Carlayne E. Jackson19
- Laura Herbelin19
- Mamatha Pasnoor18
- Wilson W. Bryan18
- Sharon Nations17
- John T. Kissel15
- Jeffrey Statland14
- Michael Benatar14
- April McVey12
- David Saperstein11
- Jonathan Katz11
- Michael G. Hanna11
- Robert G. Miller11
- Tahseen Mozaffar11
- Hiroshi Mitsumoto10
- Gary Gronseth9
- Henry J. Kaminski9
- James F. Howard9
- Jerry R. Mendell9
- Miriam Freimer9
- Alan Pestronk8
All papers
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Authors: James F. Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel, Srikanth Muppidi, Richard J. Nowak, Fanny O’Brien, Jingjing Wang, Renato Mantegazza, Claudio Mazia, Miguel Wilken, Carolina Ortea, Juliet Saba, Marcelo Rugiero, Mariela Bettini, Gonzalo Vidal, Alejandra Dalila Garcia, Phillipa J. Lamont, Wai-Kuen Leong, Heidi Boterhoven, Beverly Fyfe, L. Jackson Roberts, Mahi Jasinarachchi, Natasha Willlems, Julia Wanschitz, Wolfgang N. Löscher, Jan De Bleecker, Guy Van den Abeele, Kathy de Koning, Katrien De Mey, Rudy Mercelis, Linda Wagemaekers, Délphine Mahieu, Philip Van Damme, Charlotte Smetcoren, Olivier Stevens, Sarah Verjans, Ann D’Hondt, Petra Tilkin, Alzira Alves de Siqueira Carvalho, Rosa Hasan, Igor Dias Brockhausen, David Feder, Daniel Ambrosio, Ana Paula Souto Melo, Rosana Rocha, Bruno Bezerra Rosa, Thabata Veiga, Luiz Augusto da Silva, Jordana Gonçalves Geraldo, Maria da Penha Morita Ananias, Érica Nogueira Coelho, Gabriel Pina Paiva, M Tovar Pozo, Natália Prando, Debora Dada Martineli Torres, Cristiani Fernanda Butinhao, Érica Nogueira Coelho, Luciana Renata Cubas Volpe, Gustavo Duran, Tamires Cristina Gomes da Silva, Luiz Otavio Maia Gonçalves, Lucas Eduardo Pazetto, Luciana Souza Duca, Tomás Augusto Suriane Fialho, Maurício Friedrich, Alexandre Guerreiro, Henrique Mohr, Maurer Pereira Martins, Daiane da Cruz Pacheco, Ana Paula Macagnan, Aline de Cassia Santos, Acary Souza Bullé Oliveira, Ana Carolina Amaral de Andrade, Marcelo Annes, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Carolina Miranda, Fernanda Carrara, Iandra Souza, Angela Genge, Rami Massie, Natasha Campbell, Vera Bril, Hans Katzberg, Mehran Soltani, Eduardo Ng, Zaeem A. Siddiqi, Celile Phan, Derrick Blackmore, Stanislav Voháňka, Josef Bednařík, Magda Chmelikova, Marek Čierny and 524 more - The Lancet Neurology 2017 cited by 800
- 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Authors: Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai, Victoria P. Werth, Clarissa Pilkington, Marianne de Visser, Lars Alfredsson, Anthony A. Amato, Richard J. Barohn, Matthew H. Liang, Jasvinder A. Singh, Rohit Aggarwal, Snjólaug Arnardottir, Hector Chinoy, Robert G. Cooper, Katalin Dankó, Mazen M. Dimachkie, Brian M. Feldman, Ignacio García‐De La Torre, Patrick Gordon, Taichi Hayashi, James D. Katz, Hitoshi Kohsaka, Peter A. Lachenbruch, Bianca Lang, Yuhui Li, Chester V. Oddis, Marzena Olesińska, Ann M. Reed, Lidia Rutkowska‐Sak, Helga Sanner, Albert Selva-O’Callaghan, Yeong‐Wook Song, Jiří Vencovský, Steven R. Ytterberg, Frederick W. Miller, Lisa G. Rider - Annals of the Rheumatic Diseases 2017 cited by 1,525
- Myasthenia gravis
Authors: Alfred Jaretzki, Richard J. Barohn, Raina M. Ernstoff, Henry J. Kaminski, John Keesey, Audrey S. Penn, Donald B. Sanders - Neurology 2000 cited by 1,621
- Myasthenia gravis activities of daily living profile
Authors: Gil I. Wolfe, Laura Herbelin, Sharon Nations, Barbara Foster, Wilson W. Bryan, Richard J. Barohn - Neurology 1999 cited by 544
- Randomized Trial of Thymectomy in Myasthenia Gravis
Authors: Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, Greg Minisman, Hui‐Chien Kuo, Alexander Marx, Philipp Ströbel, Claudio Mazia, Joël Oger, Gabriel Cea, Jeannine M. Heckmann, Amelia Evoli, Wilfred A. Nix, Emma Ciafaloni, Giovanni Antonini, Rawiphan Witoonpanich, John King, Said R. Beydoun, Colin Chalk, Alexandru Barboi, Anthony A. Amato, Aziz Shaibani, Bashar Katirji, Bryan Lecky, Camilla Buckley, Angela Vincent, Elza Dias‐Tosta, Hiroaki Yoshikawa, Márcia Waddington‐Cruz, Michael Pulley, Michael H. Rivner, Anna Kostera‐Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Guillermo Ramos, Jan J.G.M. Verschuuren, Janice M. Massey, John T. Kissel, Lineu César Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Robin Conwit, Joanne Odenkirchen, Joshua Sonett, Alfred Jaretzki, John Newsom–Davis, Gary Cutter - New England Journal of Medicine 2016 cited by 905
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial
Authors: Chester V. Oddis, Ann M. Reed, Rohit Aggarwal, Lisa G. Rider, Dana P. Ascherman, Marc C. Levesque, Richard J. Barohn, Brian M. Feldman, Michael O. Harris‐Love, Diane Koontz, Noreen Fertig, Stephanie Kelley, Sherrie L. Pryber, Frederick W. Miller, Howard E. Rockette, and the RIM Study Group - Arthritis & Rheumatism 2012 cited by 691
- Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Authors: Michael Benatar, Lanyu Zhang, Lily Wang, Volkan Granit, Jeffrey Statland, Richard J. Barohn, Andrea Swenson, John Ravits, Carlayne E. Jackson, Ted M. Burns, Jaya Trivedi, Erik P. Pioro, James B. Caress, Jonathan Katz, Jacob L. McCauley, Rosa Rademakers, Andrea Malaspina, Lyle W. Ostrow, Joanne Wuu, Sumaira Hussain, Anne Cooley, Yindi Li, Marielle Wallace, Julie Steele, Jessica Hernandez, Jéssica Medina, Maria Elena Paredes, Ashley Manso, Natalia Ravelo, Wendy Levy, Patrice L. Whitehead, Stephan Züchner, Mamatha Pasnoor, Omar Jawdat, Duaa Jabari, Constantine Farmakidis, Melanie Glenn, Mazen M. Dimachkie, Laura Herbelin, Hellen Tanui, Sherri Anderson, Michaela Walker, Tina Liu, Ayla McCally, Andrew Heim, Melissa Currence, Yolanda Harness, Jeri Sieren, Emilee Gibson, G. Garcia Gutierrez, Danielle Bussey, Rose Previte, Pamella Kittrell, Amruta Joshi, Amy Conger, Debbie Hastings, Irys Caristo, Mozhdeh Marandi, Simon Carty, J. Paul Taylor, Gang Wu, Evadnie Rampersaud, Rebecca Schüle, Marka van Blitterswijk - Neurology 2020 cited by 202
- Reliability Testing of the Quantitative Myasthenia Gravis Scorea
Authors: Richard J. Barohn, Donald D. McIntire, Laura Herbelin, Gil I. Wolfe, Sharon Nations, Wilson W. Bryan - Annals of the New York Academy of Sciences 1998 cited by 404
- Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
Authors: Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel, Richard J. Nowak, Henning Andersen, Carlos Casasnovas, Jan L. De Bleecker, Tuan Vu, Renato Mantegazza, Fanny O’Brien, Jing Jing Wang, Kenji P. Fujita, James F. Howard, for the Regain Study Group - Muscle & Nerve 2019 cited by 247
- Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
Authors: Ruth Chia, Sara Sáez-Atiénzar, Natalie A. Murphy, Adriano Chiò, Cornelis Blauwendraat, Ricardo H. Roda, Pentti J. Tienari, Henry J. Kaminski, Roberta Ricciardi, Melania Guida, Anna De Rosa, Loredana Petrucci, Amelia Evoli, Carlo Provenzano, Daniel B. Drachman, Bryan J. Traynor, Yevgeniya Abramzon, Richard J. Barohn, Michael Benatar, Derrick Blackmore, Vinay Chaudhry, Adriano Chiò, Manisha Chopra, Andrea M. Corse, Anna De Rosa, Mazen M. Dimachkie, Amelia Evoli, Julaine Florence, Miriam Freimer, Melania Guida, James F. Howard, Theresa Jiwa, Henry J. Kaminski, John T. Kissel, Wilma J. Koopman, Bernadette Lipscomb, Michelangelo Maestri, Mariapaola Marino, Janice M. Massey, April McVey, Michelle M. Mezei, Srikanth Muppidi, Michael Nicolle, Joël Oger, Robert M. Pascuzzi, Mamatha Pasnoor, Alan Pestronk, Loredana Petrucci, Hannah A. Pliner, Carlo Provenzano, Alan E. Renton, Roberta Ricciardi, David P. Richman, Julie Rowin, Donald B. Sanders, Mario Sabatelli, Zaeem A. Siddiqi, Aimee Soloway, Laura Todi, Gil I. Wolfe, Charlie Wulf, Daniel B. Drachman, Bryan J. Traynor - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 132
- Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy
Authors: Michela Guglieri, Kate Bushby, Michael McDermott, P. Morehart, Rabi Tawil, William B. Martens, Barbara E. Herr, Elaine McColl, Chris Speed, Jennifer Wilkinson, Janbernd Kirschner, Wendy King, Michelle Eagle, Mary W. Brown, Tracey Willis, Robert C. Griggs, FOR-DMD Investigators of the Muscle Study Group, Volker Straub, Henriette van Ruiten, Anne‐Marie Childs, Emma Ciafaloni, Perry B. Shieh, Stefan Spinty, Lorenzo Maggi, Giovanni Baranello, Russell J. Butterfield, Iain Horrocks, Helen Roper, Z. Alhaswani, Kevin M. Flanigan, Nancy L. Kuntz, Adnan Manzur, Basil T. Darras, Peter B. Kang, Leslie Morrison, Monika Krzesniak‐Swinarska, Jean K. Mah, Tiziana Mongini, Federica Ricci, Maja von der Hagen, Richard S. Finkel, Kathleen O’Reardon, Matthew Wicklund, Ashutosh Kumar, Craig M. McDonald, Jay J. Han, Nanette C. Joyce, Erik Henricson, Ulrike Schara‐Schmidt, Andrea Gangfuß, Ekkehard Wilichowski, Richard J. Barohn, Jeffrey Statland, Craig Campbell, Giuseppe Vita, Gian Luca Vita, James F. Howard, Imelda Hughes, Hugh J. McMillan, Elena Pegoraro, Luca Bello, W. Bryan Burnette, Mathula Thangarajh, Taeun Chang - JAMA 2022 cited by 123
- Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
Authors: Steven A. Greenberg, Jack L. Pinkus, Geraldine S. Pinkus, Travis Burleson, Despina Sanoudou, Rabi Tawil, Richard J. Barohn, David Saperstein, Hannah Briemberg, Maria Ericsson, Peter J. Park, Anthony A. Amato - Annals of Neurology 2005 cited by 612
- Primary lateral sclerosis: consensus diagnostic criteria
Authors: Martin R. Turner, Richard J. Barohn, Philippe Corcia, John K. Fink, Matthew B. Harms, Matthew C. Kiernan, John Ravits, Vincenzo Silani, Zachary Simmons, Jeffrey Statland, Leonard H. van den Berg, Delegates of the 2nd International PLS Conference, Hiroshi Mitsumoto - Journal of Neurology Neurosurgery & Psychiatry 2020 cited by 244
- Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis
Authors: James F. Howard, Richard J. Nowak, Gil I. Wolfe, Miriam Freimer, Tuan Vu, John L. Hinton, Michael Benatar, Petra W. Duda, James E. MacDougall, Ramin Farzaneh‐Far, Henry J. Kaminski, and the Zilucoplan MG Study Group, Richard J. Barohn, Mazen M. Dimachkie, Mamatha Pasnoor, Constantine Farmakidis, Tina Liu, Samantha Colgan, Michael Benatar, Tulio E. Bertorini, Rekha Pillai, Robert Henegar, Mark B. Bromberg, Summer Gibson, Teresa Janecki, Miriam Freimer, Bakri Elsheikh, Paige Matisak, Angela Genge, Amanda C. Guidon, William David, Ali A. Habib, Veena Mathew, Tahseen Mozaffar, John L. Hinton, William L. Hewitt, Deborah Barnett, Patricia Sullivan, Doreen Ho, James F. Howard, Rebecca Traub, Manisha Chopra, Henry J. Kaminski, Radwa Aly, Elham Bayat, Mohammad Abu-Rub, Shaida Khan, Dale J. Lange, Shara Holzberg, Bhupendra Khatri, Emily Lindman, Tayo Olapo, Lisa Sershon, Robert P. Lisak, Evanthia Bernitsas, Kelly Jia, Rabia Malik, Tiffany D. Lewis-Collins, Michael Nicolle, Richard J. Nowak, Aditi Sharma, Bhaskar Roy, Joan Nye, Michael Pulley, Alan Ross Berger, Yasmeen Shabbir, Amit Sachdev, Kimberly Patterson, Zaeem A. Siddiqi, Mark Sivak, Joan Bratton, George A. Small, Anem Kohli, Mary Fetter, Tuan Vu, Lucy Lam, Brittany Harvey, Gil I. Wolfe, Nicholas J. Silvestri, Kara Patrick, Karen Zakalik, Petra W. Duda, James E. MacDougall, Ramin Farzaneh-Far, Angela Pontius, Michelle D. Hoarty - JAMA Neurology 2020 cited by 193
- Treatment of Myasthenia Gravis
Authors: Constantine Farmakidis, Mamatha Pasnoor, Mazen M. Dimachkie, Richard J. Barohn - Neurologic Clinics 2018 cited by 238
- Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Authors: Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, Greg Minisman, Hui‐Chien Kuo, Alexander Marx, Philipp Ströbel, Claudio Mazia, Joël Oger, Gabriel Cea, Jeannine M. Heckmann, Amelia Evoli, Wilfred A. Nix, Emma Ciafaloni, Giovanni Antonini, Rawiphan Witoonpanich, John King, Said R. Beydoun, Colin Chalk, Alexandru Barboi, Anthony A. Amato, Aziz Shaibani, Bashar Katirji, Bryan Lecky, Camilla Buckley, Angela Vincent, Elza Dias‐Tosta, Hiroaki Yoshikawa, Márcia Waddington‐Cruz, Michael Pulley, Michael H. Rivner, Anna Kostera‐Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Jan J.G.M. Verschuuren, Janice M. Massey, John T. Kissel, Lineu César Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Nicholas J. Silvestri, Robin Conwit, Joshua Sonett, Alfred Jaretzki, John Newsom–Davis, Gary Cutter, Gary Cutter, Inmaculada Aban, Greg Minisman, Michelle Feese, Hui‐Chien Kuo, John Newsom–Davis, Gil I. Wolfe, Henry J. Kaminski, Alfred Jaretzki, Joshua Sonett, Claudio Mazia, Valeria Saluto, Moisés Rosenberg, Valeria Alvarez, Lisa A. Rocca Rey, John King, Helmut Butzkueven, John Goldblatt, John C. Carey, John R. Pollard, Stephen Reddel, Nicholas Handel, Brian C. McCaughan, Linda Pallot, Márcia Waddington‐Cruz, Ricardo Novis, Carlos Henrique Ribeiro Boasquevisque, Elza Dias‐Tosta, Rubens N. Morato-Fernandez, Manoel Ximenes, Lineu César Werneck, Rosana Hermínia Scola, Paulo Soltoski, Colin Chalk, Fraser Moore, David S. Mulder, Lisa Wadup, Joël Oger, Michele Mezei, Kenneth G. Evans, Theresa Jiwa, Anne Schaffar, Chris White, Cory Toth, Gary Gelfand, Susan P. Wood, Elizabeth Pringle, Jocelyn Zwicker, Donna E. Maziak, Farid M. Shamji, Sudhir Sundaresan, Andrew Seely and 247 more - The Lancet Neurology 2019 cited by 223
- Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Authors: Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, Richard S. Finkel, Kevin M. Flanigan, Nathalie Goemans, Peter Heydemann, Anna Kamińska, Janbernd Kirschner, Francesco Muntoni, A. Nascimento Osorio, Ulrike Schara, Thomas Sejersen, Perry B. Shieh, H. Lee Sweeney, Haluk Topaloğlu, M. Tulinius, Juan J. Vílchez, Thomas Voït, Brenda Wong, Gary Elfring, Hans Kröger, Xiaohui Luo, Joseph McIntosh, Tuyen Ong, Peter Riebling, Marcio Ferreira de Souza, Robert J. Spiegel, Stuart W. Peltz, Eugenio Mercuri, Lindsay N. Alfano, Michelle Eagle, M. James, Linda Lowes, Anna Mayhew, Elena Mazzone, Leslie Nelson, Kristy Rose, Hoda Abdel‐Hamid, Susan Apkon, Richard J. Barohn, Enrico Bertini, Clemens Bloetzer, Lausanne Canton de Vaud, Russell J. Butterfield, B. Chabrol, Jong‐Hee Chae, Daehak-ro Jongno-gu, Giacomi Pietro Comi, Basil T. Darras, Jahannaz Dastgir, Isabelle Desguerre, Raúl G. Escobar, Erika Finanger, Michela Guglieri, Imelda Hughes, Susan T. Iannaccone, Kristi Jones, Peter Karachunski, Martin Kudr, Timothy Lotze, Jean K. Mah, Katherine D. Mathews, Yoram Nevo, Julie Parsons, Yann Péréon, Alexandra Prufer de Queiroz Campos Araújo, J. Ben Renfroe, Maria Bernadete Dutra de Resende, Monique M. Ryan, Kathryn Selby, Gihan Tennekoon, Giuseppe Vita - The Lancet 2017 cited by 455
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
Authors: Richard J. Nowak, Christopher S. Coffey, Jonathan M. Goldstein, Mazen M. Dimachkie, Michael Benatar, John T. Kissel, Gil I. Wolfe, Ted M. Burns, Miriam L. Freimer, Sharon Nations, Volkan Granit, A. Gordon Smith, David P. Richman, Emma Ciafaloni, Muhammad T. Al-Lozi, Laura Ann Sams, Dianna Quan, Eroboghene Ubogu, Brenda Pearson, Aditi Sharma, Jon W. Yankey, Liz Uribe, Michael Shy, Anthony A. Amato, Robin Conwit, Kevin C. O'Connor, David A. Hafler, Merit E. Cudkowicz, Richard J. Barohn, on behalf of the NeuroNEXT NN103 BeatMG Study Team - Neurology 2021 cited by 134
- Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
Authors: K. Hewett, Donald B. Sanders, Richard Grove, Christine L. Broderick, Todd Rudo, Ashlyn Bassiri, Marina Zvartau‐Hind, Vera Bril, On behalf of the BEL115123 Study Group, BEL115123 Study Group, Laurence Adams, Sankar Bandyopadhyay, Said R. Beydoun, Felix Bischof, Mazen M. Dimachkie, Miriam Freimer, Maurizio Inghilleri, Henry J. Kaminski, Renato Mantegazza, Tahseen Mozaffar, Michael Nicolle, Khema R. Sharma, Zaeemi Siddiqi, Ericka Simpson, Florian Then Bergh, Tuan Vu, Radwa Aly, Carlo Antozzi, Richard J. Barohn, Derrick Blackmore, Silvia Bonanno, Angela Campanella, Tiyonnoh Cash, Bakri Elsheikh, Vittorio Frasca, Namita Goyal, Brittany Harvey, Eugene C. Lai, Lorenzo Maggi, Brian Minton, Verónica Puertas‐Martín, Emanuela Onesti, Mamatha Pasnoor, Gulmohor Roy, Sheetal Shroff, Jason R. Thonhoff - Neurology 2018 cited by 128
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
Authors: Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy M. Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne D. Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen‐Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven Novella, Terry Heiman‐Patterson, Edward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra I. Barsdorf, Hiroshi Mitsumoto, Bruce Levin - Annals of Neurology 2009 cited by 235
- Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Authors: Paul H Gordon, Dan H. Moore, Robert G. Miller, Julaine Florence, Joseph L. Verheijde, Carolyn Doorish, Joan F. Hilton, G. Mark Spitalny, Robert B. MacArthur, Hiroshi Mitsumoto, Hans E. Neville, Khrista Boylan, Tahseen Mozaffar, Jerry M. Belsh, John Ravits, Richard Bedlack, Michael C. Graves, Leo McCluskey, Richard J. Barohn, Rup Tandan - The Lancet Neurology 2007 cited by 642
- Myasthenia gravis: recommendations for clinical research standards
Authors: Alfred Jaretzki, Richard J. Barohn, Raina M. Ernstoff, Henry J. Kaminski, John Keesey, Audrey S. Penn, Donald B. Sanders - The Annals of Thoracic Surgery 2000 cited by 642
- Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Authors: Michael G. Hanna, Umesh A. Badrising, Olivier Benvéniste, Thomas E. Lloyd, Merrilee Needham, Hector Chinoy, Masashi Aoki, Pedro Machado, Christina Liang, Katrina Reardon, Marianne de Visser, Dana P. Ascherman, Richard J. Barohn, Mazen M. Dimachkie, James Miller, John T. Kissel, Björn Oskarsson, Nanette C. Joyce, Peter Van den Bergh, Jonathan Baets, Jan De Bleecker, Chafic Karam, William S. David, Massimiliano Mirabella, Sharon Nations, Hans H. Jung, Elena Pegoraro, Lorenzo Maggi, Carmelo Rodolico, Massimiliano Filosto, Aziz Shaibani, Kumaraswamy Sivakumar, Namita Goyal, Madoka Mori‐Yoshimura, Satoshi Yamashita, Naoki Suzuki, Masahisa Katsuno, Kenya Murata, Hiroyuki Nodera, Ichizo Nishino, Carla D Romano, Valerie Williams, John Vissing, Lixin Zhang Auberson, Min Wu, Ana de Vera, Dimitris A. Papanicolaou, Anthony A. Amato - The Lancet Neurology 2019 cited by 133
- Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
Authors: Andrew L. Mammen, Anthony A. Amato, Mazen M. Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker, Iago Pinal‐Fernandez, Yves Allenbach, Babak Boroojerdi, Mark Vanderkelen, Eumorphia Maria Delicha, Harold Koendgen, Ramin Farzaneh‐Far, Petra W. Duda, Camil Sayegh, Olivier Benvéniste, Anthony A. Amato, Olivier Benveniste, Suur Biliciler, Hector Chinoy, Mazen M. Dimachkie, Christyn Edmundson, Miriam Freimer, Anthony Geraci, Yessar Hussain, Pedro Machado, Andrew L. Mammen, Tahseen Mozaffar, Payam Soltanzadeh, Niraja Suresh, Anneke van der Kooi, Yves Allenbach, Matthew Appleby, Richard J Barohn, Nicolas Champtiaux, Christopher Doughty, Jerrica Farias, Constantine Farmakidis, Ali A. Habib, Chafic Karam, James Lilleker, Samantha Lorusso, Mamatha Pasnoor, Iago Pinal-Fernandez, Giorgia Querin, Joost Raaphorst, George Ransley, Sami Saba, Kazim Sheikh, Andrew Snedden, Jeffrey Statland, Tuan Vu - The Lancet Rheumatology 2023 cited by 55
